ArticleThe Journal of clinical investigation2018

Tumor-infiltrating BRAFV600E-specific CD4+ T cells correlated with complete clinical response in melanoma.

Joshua R Veatch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.